These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 16684687)

  • 1. Addressing the limitations of the CATIE study.
    Kasper S; Winkler D
    World J Biol Psychiatry; 2006; 7(2):126-7. PubMed ID: 16684687
    [No Abstract]   [Full Text] [Related]  

  • 2. The CATIE study and its implications for antipsychotic drug use.
    Janicak PG
    Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293
    [No Abstract]   [Full Text] [Related]  

  • 3. Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study.
    Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):371-2. PubMed ID: 16382376
    [No Abstract]   [Full Text] [Related]  

  • 4. Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs.
    Angst J; Bech P; Bobon D; Engel R; Hippius H; Janzen GJ; Lecrubier Y; Lingjaerde O; Möller HJ; Montgomery S
    Pharmacopsychiatry; 1991 Sep; 24(5):149-52. PubMed ID: 1685571
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of cyamemazine].
    Nurowska K
    Psychiatr Pol; 1983; 17(5-6):389-95. PubMed ID: 6142492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pro and contra: basic precedence of atypical neuroleptics].
    Naber D; Dose M
    Psychiatr Prax; 2005 May; 32(4):163-6. PubMed ID: 15852207
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controversy regarding psychosis therapy].
    Echarri Arrieta E
    Farm Hosp; 2004; 28(3):149-53. PubMed ID: 15222868
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.
    Gerlach M; Hünnerkopf R; Rothenhöfer S; Libal G; Burger R; Clement HW; Fegert JM; Wewetzer Ch; Mehler-Wex C
    Pharmacopsychiatry; 2007 Mar; 40(2):72-6. PubMed ID: 17447177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
    Weiden PJ
    J Clin Psychiatry; 2007; 68 Suppl 1():12-9. PubMed ID: 17286523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial going on for 10 years - how is it possible?
    Mimica N; Folnegović-Smalc V; Uzun S; Kozumplik O
    Psychiatr Danub; 2009 Sep; 21(3):329. PubMed ID: 19794350
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
    Nasrallah HA
    J Clin Psychiatry; 2007; 68 Suppl 1():3-4. PubMed ID: 17286521
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
    Nosè M; Tansella M; Thornicroft G; Schene A; Becker T; Veronese A; Leese M; Koeter M; Angermeyer M; Barbui C
    Int Clin Psychopharmacol; 2008 Sep; 23(5):287-90. PubMed ID: 18703938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological management of behavioural disturbance in psychosis: a naturalistic study.
    Daniel J; Chamberlain J; Castle D
    Australas Psychiatry; 2007 Oct; 15(5):380-4. PubMed ID: 17828634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drug therapy: current status.
    J Clin Psychiatry; 1996; 57 Suppl 9():2-76. PubMed ID: 8847339
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
    van Berkel M; Bogers JP; Bouvy PF
    Tijdschr Psychiatr; 2007; 49(1):37-41. PubMed ID: 17225204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
    Richtand NM; Welge JA; Logue AD; Keck PE; Strakowski SM; McNamara RK
    Prog Brain Res; 2008; 172():155-75. PubMed ID: 18772032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer antipsychotics and the differences between clinical experiences and clinical trials. Interview by Norman Sussman, MD.
    Marder SR
    CNS Spectr; 2007 Nov; 12(11):812-5. PubMed ID: 18084854
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of psychotic disorders in the elderly.
    Kirkwood CK
    Director; 2003; 11(4):160, 163-5. PubMed ID: 14608700
    [No Abstract]   [Full Text] [Related]  

  • 20. Duration of risperidone treatment for BPSD.
    Snowdon J; Brodaty H; Ames D; Day S
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):699-701. PubMed ID: 16821255
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.